§ BIOTECHNOLOGY
USD · BiotechnologyAKBA
AKEBIA THERAPEUTICS INC
USDSector · BiotechnologyBeta · 0.21
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX
§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY
13F FLOW
107 increased/new, 33 decreased/exited (13F)
AC 13F Analysis
§ 04 · FUNDAMENTALS · THE BOOKS
| P/B | 13.10 | EPS (TTM) | -0.11 |
§ 05 · WHO OWNS IT
Top institutional holders
| Fund | Shares | % port | Δ Q/Q |
|---|---|---|---|
| BlackRock | 18.7M | 0.0% | −3% |
| State Street | 11.6M | 0.0% | −15% |
| VANGUARD CAPITAL MANAGEMENT LLC | 11.2M | n/a | n/a |
| Geode Capital Management | 6.5M | 0.0% | +3% |
| Goldman Sachs | 3.6M | 0.0% | −23% |
| Citigroup Inc | 2.9M | 0.0% | +17% |
◇ AC INTELLIGENCE
Top institutional owners for AKBA as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.
§ 06 · WHO OWNS IT · BY STRATEGY
OTHER57.5% · 0 holders
OTHER17.9% · 118 holders
PASSIVE / INDEX10.6% · 8 holders
DEALER / BANK9.8% · 17 holders
QUALITY / COMPOUNDER1.6% · 11 holders
TACTICAL / MACRO1.5% · 3 holders
SYSTEMATIC / QUANT0.9% · 5 holders
GROWTH / MOMENTUM0.1% · 1 holder
INCOME / DEFENSIVE0.1% · 7 holders
ACTIVIST0.0% · 1 holder
◇ AC INTELLIGENCE
Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.
§ 07 · INSIDER ACTIVITY · LAST 180 DAYS
NO INSIDER FILINGS
◇ AC INTELLIGENCE
No Form 4 filings on record for AKBA in the last 180 days.
§ 08 · COVERAGE · OUR RECENT NOTES
No notes mention AKBA yet.